Rationale

Minority patients have often been underrepresented in clinical trials. Despite various safety, clinical, regulatory, commercial and ethical needs to increase the representativeness of trials, study teams are often unaware of the need for diversity and the resources available to improve the recruitment and retention rates of racially and ethnically diverse populations.

A broader recognition of the benefits and techniques of improving diversity in clinical trials is needed. TransCelerate’s Clinical Trial Diversification Initiative enhances the racial and ethnic diversity of clinical trial populations by helping sponsors achieve trials that are representative of the indicated population.

Benefits

The initiative has developed sponsor and clinical trial site guidance on better practices and processes for minority recruitment. The guidance focuses on six key areas, including diversity awareness, patient engagement, cultural competency, reimbursement IRB insights, informed consent and community engagement.

Available Assets

The initiative has developed sponsor and clinical trial site guidance on better practices and processes for minority recruitment. The guidance focuses on six key areas.

Similar Initiatives

Pediatric Trial Efficiencies

LEARN MORE >

eLabels

LEARN MORE >

Placebo and Standard of Care Data Sharing

LEARN MORE >